DotBio is developing an internal pipeline of innovative, multi-specific antibody therapies to treat and cure cancer.

Some of our assets in development are presented here:

Pipeline.png

 WE ARE LOOKING FOR PARTNERS AND INVESTORS

 

Partners

We are looking for pharma partners, under different partnership modalities:

  • Co-development of specific DotBody assets

  • Out-licensing of DotBody assets

  • Access to our DotBody platform

INVESTORS

We are looking for investors for our upcoming Series A round:

  • To expand pipeline

  • To increase our capabilities

  • To bring two DotBody assets to IND-filing

Contact: info@dotbiopharma.com